# EDGAR Filing Document

**Accession Number:** 0001810560
**File Stem:** 0001193125-25-223620
**Filing Date:** 2025-9
**Character Count:** 1973
**Document Hash:** 83d7179a9494e3d41ee69ba6033f5e2f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-223620.hdr.sgml**: 20260625

**ACCESSION NUMBER**: 0001193125-25-223620

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250929

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REVELATION BIOSCIENCES, INC.
- **CENTRAL INDEX KEY:** 0001810560
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 843898466
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 4660 LAJOLLA VILLAGE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92122
- **BUSINESS PHONE:** 650-800-3717

**MAIL ADDRESS:**
- **STREET 1:** 4660 LAJOLLA VILLAGE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92122

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Petra Acquisition Inc.
- **DATE OF NAME CHANGE:** 20200423

**Revelation Biosciences, Inc.**

**4660 La Jolla Village Drive, Suite 100**

**San Diego, California 92122**

September 30, 2025

*<u>Via EDGAR</u>*

Division of Corporate Finance

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Attention: Jimmy McNamara <br> Alan Campbell

---

| | |
|:---|:---|
| Re: | Revelation Biosciences, Inc. |
|  | Registration Statement on Form S-3 |
|  | Commission File No. 333-29039 |

---

Messrs. McNamara and Campbell:

On behalf of Revelation Biosciences, Inc. (the "Company"), I hereby request that the Commission declare effective the above-captioned registration statement at 5:00pm on September 30, 2025, or as soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments.

---

| |
|:---|
| Very truly yours, |
| Revelation Biosciences, Inc. |
| <u>/s/ Chester S. Zygmont, III</u> |
| Chief Financial Officer |

---

------